IN2014KN00892A - - Google Patents

Download PDF

Info

Publication number
IN2014KN00892A
IN2014KN00892A IN892KON2014A IN2014KN00892A IN 2014KN00892 A IN2014KN00892 A IN 2014KN00892A IN 892KON2014 A IN892KON2014 A IN 892KON2014A IN 2014KN00892 A IN2014KN00892 A IN 2014KN00892A
Authority
IN
India
Prior art keywords
pharmaceutical composition
disclosed
impurity content
low impurity
caspofungin pharmaceutical
Prior art date
Application number
Other languages
English (en)
Inventor
Yunhai Hong
Ying Xue
Lixin Sha
Xiaoming Ji
Original Assignee
Shanghai Techwell Biopharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shanghai Techwell Biopharm Co filed Critical Shanghai Techwell Biopharm Co
Publication of IN2014KN00892A publication Critical patent/IN2014KN00892A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IN892KON2014 2011-09-26 2012-09-25 IN2014KN00892A (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
CN201110288753 2011-09-26
CN201110433680.2A CN102488886B (zh) 2011-09-26 2011-12-21 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
PCT/CN2012/081956 WO2013044789A1 (zh) 2011-09-26 2012-09-25 一种低杂质含量的卡泊芬净制剂及其制备方法和用途

Publications (1)

Publication Number Publication Date
IN2014KN00892A true IN2014KN00892A (ko) 2015-10-09

Family

ID=46180778

Family Applications (1)

Application Number Title Priority Date Filing Date
IN892KON2014 IN2014KN00892A (ko) 2011-09-26 2012-09-25

Country Status (7)

Country Link
US (1) US9149435B2 (ko)
KR (1) KR101720396B1 (ko)
CN (2) CN102488886B (ko)
DE (1) DE112012003995T5 (ko)
ES (1) ES2495615B1 (ko)
IN (1) IN2014KN00892A (ko)
WO (1) WO2013044789A1 (ko)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102488886B (zh) 2011-09-26 2014-03-26 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN103386117B (zh) 2011-09-26 2015-09-30 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN103212058A (zh) * 2012-01-18 2013-07-24 江苏恒瑞医药股份有限公司 含有抗真菌药物和乳酸盐缓冲剂的组合物
CN103539841A (zh) * 2012-07-12 2014-01-29 重庆乾泰生物医药有限公司 一种环己肽类化合物及其盐的分离纯化方法
KR20140123782A (ko) * 2013-04-15 2014-10-23 에스케이케미칼주식회사 카스포펀진 및 완충제를 포함하는 안정성이 개선된 약학적 조성물
CN106860856B (zh) * 2015-12-14 2019-05-31 山东新时代药业有限公司 一种含有阿尼芬净的冻干粉及制备方法
CN108760937B (zh) * 2018-07-27 2020-12-29 杭州华东医药集团新药研究院有限公司 醋酸卡泊芬净中残留乙二胺的测定及其应用
CN109394707A (zh) * 2018-12-26 2019-03-01 四川制药制剂有限公司 一种注射用醋酸卡泊芬净的制造方法
CN109568275B (zh) * 2019-01-10 2021-08-27 杭州华东医药集团新药研究院有限公司 一种含醋酸卡泊芬净的冻干组合物及其制备方法

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
AR006598A1 (es) * 1996-04-19 1999-09-08 Merck Sharp & Dohme "composiciones anti-fungosas, su uso en la manufactura de medicamentos y un procedimiento para su preparación"
US5952300A (en) * 1996-04-19 1999-09-14 Merck & Co., Inc. Antifungal compositions
WO2000051564A1 (en) * 1999-03-03 2000-09-08 Eli Lilly And Company Echinocandin pharmaceutical formulations containing micelle-forming surfactants
US6586574B1 (en) * 1999-08-17 2003-07-01 Nn A/S Stabilization of freeze-dried cake
US6954253B2 (en) 2000-07-25 2005-10-11 Scientific Solutions, Inc. Optical multiplexer and cross-switch using etched liquid crystal fabry-perot etalons
WO2002055022A2 (en) * 2001-01-09 2002-07-18 Merck & Co., Inc. Active metabolite of antifungal compound
CN101516387B (zh) * 2006-07-26 2014-06-04 桑多斯股份公司 卡泊芬净制剂
MX2009012964A (es) * 2007-06-01 2010-01-14 Acologix Inc Formulacion de peptido estable a alta temperatura.
WO2009002481A1 (en) * 2007-06-26 2008-12-31 Merck & Co., Inc. Lyophilized anti-fungal composition
WO2009142761A1 (en) * 2008-05-21 2009-11-26 Teva Gyogyszergyar Zartkoruen Mukodo Reszvenytarsasag Caspofungin bo free of caspofungin co
WO2010008493A2 (en) * 2008-06-25 2010-01-21 Teva Gyógyszergyár Zártkörüen Müködö Részvénytársaság Processes for preparing high purity aza cyclohexapeptides
KR20110011704A (ko) * 2008-06-25 2011-02-08 테바 기오기스제르갸르 자르트쾨렌 뮈쾨되 레스즈베니타르사사그 카스포펀진 불순물 ａ를 함유하지 않는 카스포펀진
CN102219832B (zh) * 2010-04-15 2013-08-21 上海天伟生物制药有限公司 一种氮杂环六肽或其盐的纯化方法
CN102153616A (zh) * 2010-12-27 2011-08-17 浙江海正药业股份有限公司 一种环己肽类化合物及其盐的分离纯化方法
CN103386117B (zh) 2011-09-26 2015-09-30 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途
CN102488886B (zh) 2011-09-26 2014-03-26 上海天伟生物制药有限公司 一种低杂质含量的卡泊芬净制剂及其制备方法和用途

Also Published As

Publication number Publication date
CN102488886B (zh) 2014-03-26
DE112012003995T5 (de) 2014-08-21
WO2013044789A1 (zh) 2013-04-04
CN103315969A (zh) 2013-09-25
US9149435B2 (en) 2015-10-06
CN103315969B (zh) 2016-05-18
CN102488886A (zh) 2012-06-13
ES2495615R1 (es) 2014-11-12
KR20140069273A (ko) 2014-06-09
US20140228280A1 (en) 2014-08-14
ES2495615B1 (es) 2015-08-19
KR101720396B1 (ko) 2017-03-27
ES2495615A2 (es) 2014-09-17

Similar Documents

Publication Publication Date Title
IN2014KN00892A (ko)
EP2719190B8 (en) Spatially-segmented content delivery
HK1215817A1 (zh) 內容遞送框架
HK1203016A1 (en) Techniques for improved multicast content delivery
HUE041889T2 (hu) Releváns tartalom kézbesítése
MX2013012542A (es) Compuestos de amida y aplicacion farmaceutica para el mismo.
MX2013001045A (es) Organoide hepatico, sus usos y metodo de cultivo para obtenerlos.
MY168300A (en) Pharmaceutical Composition for Inhalation
EP2736532A4 (en) COMPOSITIONS AND METHODS FOR IMPROVING THE EFFICACY AND WIDTH OF HIV ANTIBODIES
EP2676671A4 (en) METHOD FOR THE PREPARATION OF A PHARMACEUTICAL COMPOSITION FOR IMPROVING IMMUNITY AND THEREFORE PRODUCED PHARMACEUTICAL COMPOSITION
TW201144301A (en) Processes for preparing linezolid
EP2672989A4 (en) IMMUNOGENIC COMPOSITION WITH ALPHA-HEMOLYSIN OLIGOPEPTIDES
EP2939662A4 (en) TEMOCOLOMIDE-CONTAINING PHARMACEUTICAL COMPOSITION WITH IMPROVED STABILITY AND METHOD OF MANUFACTURING THEREOF
CA144465S (en) Landscape edger
FI3564378T3 (fi) Immunogeeninen koostumus
IN2014KN00893A (ko)
EP2726969A4 (en) DISPLAY OF CONTENT
EA033171B1 (ru) Полутвёрдая фармацевтическая композиция на водной основе, содержащая тапентадол
MX2016008369A (es) Composicion farmaceutica que incluye palonosetron.
EP2797319A4 (en) CONTENT DELIVERY SYSTEM
CA144467S (en) Landscape edger
GB2504042B (en) Caspofungin or salts thereof with high purity, as well as preparation method and use thereof
ZA201306419B (en) Compositions and methods for separating,characterizing and administering soluble selenoglycoproteins
MX2014006201A (es) Formas de dosificaciones solidas de imatinib reconstituidas justo antes de usarse.
MX2013013558A (es) Composicion farmaceutica.